| Dr Daryl Christopher Osbahr, MD | |
|
255 N Lakemont Ave Ste 207, Winter Park, FL 32792-3219 | |
| (407) 852-5333 | |
| (407) 743-3050 |
| Full Name | Dr Daryl Christopher Osbahr |
|---|---|
| Gender | Male |
| Speciality | Sports Medicine |
| Experience | 19 Years |
| Location | 255 N Lakemont Ave Ste 207, Winter Park, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699944017 | NPI | - | NPPES |
| ME117956 | Other | FL | MEDICAL LICENSE |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventhealth Orlando | Orlando, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rothman Orthopaedics Of Florida,pllc | 4880009786 | 76 |
News Archive
During Low Vision Awareness Month, the National Eye Institute (NEI), part of the National Institutes of Health, is highlighting new technologies and tools in the works to help the 4.1 million Americans living with low vision or blindness.
Emergent Group Inc., a leading provider of mobile medical lasers and surgical equipment, today announced that the Board of Directors has declared a special, one-time cash dividend of $0.50 per share on its common stock as well as a regular dividend of $0.40 per share, for a total of $0.90 payable December 27, 2010 to shareholders of record December 17, 2010.
Women & Infants Hospital of Rhode Island has been named a Center of Excellence for Reproductive Resource Services by OptumHealth, an independent audit company.
The positive results of the first nationwide clinical study showing the benefits of an antiangiogenic agent in breast cancer therapy are reported in the Dec. 27 issue of the New England Journal of Medicine.
A practice-changing study, NRG Oncology clinical trial NRG-RTOG 9802, has demonstrated, for the first time, a survival benefit of adjuvant chemotherapy following radiotherapy over radiotherapy alone in certain subgroups of patients with high-risk, low-grade glioma (WHO classification: LGG, grade II), a type of brain tumor that originates from glial cells.
› Verified 3 days ago
| Entity Name | Florida Hospital Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225034234 PECOS PAC ID: 0749186153 Enrollment ID: O20031208000807 |
News Archive
During Low Vision Awareness Month, the National Eye Institute (NEI), part of the National Institutes of Health, is highlighting new technologies and tools in the works to help the 4.1 million Americans living with low vision or blindness.
Emergent Group Inc., a leading provider of mobile medical lasers and surgical equipment, today announced that the Board of Directors has declared a special, one-time cash dividend of $0.50 per share on its common stock as well as a regular dividend of $0.40 per share, for a total of $0.90 payable December 27, 2010 to shareholders of record December 17, 2010.
Women & Infants Hospital of Rhode Island has been named a Center of Excellence for Reproductive Resource Services by OptumHealth, an independent audit company.
The positive results of the first nationwide clinical study showing the benefits of an antiangiogenic agent in breast cancer therapy are reported in the Dec. 27 issue of the New England Journal of Medicine.
A practice-changing study, NRG Oncology clinical trial NRG-RTOG 9802, has demonstrated, for the first time, a survival benefit of adjuvant chemotherapy following radiotherapy over radiotherapy alone in certain subgroups of patients with high-risk, low-grade glioma (WHO classification: LGG, grade II), a type of brain tumor that originates from glial cells.
› Verified 3 days ago
| Entity Name | Orlando Health Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669429577 PECOS PAC ID: 9537059084 Enrollment ID: O20040318000044 |
News Archive
During Low Vision Awareness Month, the National Eye Institute (NEI), part of the National Institutes of Health, is highlighting new technologies and tools in the works to help the 4.1 million Americans living with low vision or blindness.
Emergent Group Inc., a leading provider of mobile medical lasers and surgical equipment, today announced that the Board of Directors has declared a special, one-time cash dividend of $0.50 per share on its common stock as well as a regular dividend of $0.40 per share, for a total of $0.90 payable December 27, 2010 to shareholders of record December 17, 2010.
Women & Infants Hospital of Rhode Island has been named a Center of Excellence for Reproductive Resource Services by OptumHealth, an independent audit company.
The positive results of the first nationwide clinical study showing the benefits of an antiangiogenic agent in breast cancer therapy are reported in the Dec. 27 issue of the New England Journal of Medicine.
A practice-changing study, NRG Oncology clinical trial NRG-RTOG 9802, has demonstrated, for the first time, a survival benefit of adjuvant chemotherapy following radiotherapy over radiotherapy alone in certain subgroups of patients with high-risk, low-grade glioma (WHO classification: LGG, grade II), a type of brain tumor that originates from glial cells.
› Verified 3 days ago
| Entity Name | Rothman Orthopaedics Of Florida,pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669086872 PECOS PAC ID: 4880009786 Enrollment ID: O20210225002644 |
News Archive
During Low Vision Awareness Month, the National Eye Institute (NEI), part of the National Institutes of Health, is highlighting new technologies and tools in the works to help the 4.1 million Americans living with low vision or blindness.
Emergent Group Inc., a leading provider of mobile medical lasers and surgical equipment, today announced that the Board of Directors has declared a special, one-time cash dividend of $0.50 per share on its common stock as well as a regular dividend of $0.40 per share, for a total of $0.90 payable December 27, 2010 to shareholders of record December 17, 2010.
Women & Infants Hospital of Rhode Island has been named a Center of Excellence for Reproductive Resource Services by OptumHealth, an independent audit company.
The positive results of the first nationwide clinical study showing the benefits of an antiangiogenic agent in breast cancer therapy are reported in the Dec. 27 issue of the New England Journal of Medicine.
A practice-changing study, NRG Oncology clinical trial NRG-RTOG 9802, has demonstrated, for the first time, a survival benefit of adjuvant chemotherapy following radiotherapy over radiotherapy alone in certain subgroups of patients with high-risk, low-grade glioma (WHO classification: LGG, grade II), a type of brain tumor that originates from glial cells.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Daryl Christopher Osbahr, MD 833 Chestnut St Ste 520, Philadelphia, PA 19107-4430 Ph: (609) 677-7003 | Dr Daryl Christopher Osbahr, MD 255 N Lakemont Ave Ste 207, Winter Park, FL 32792-3219 Ph: (407) 852-5333 |
News Archive
During Low Vision Awareness Month, the National Eye Institute (NEI), part of the National Institutes of Health, is highlighting new technologies and tools in the works to help the 4.1 million Americans living with low vision or blindness.
Emergent Group Inc., a leading provider of mobile medical lasers and surgical equipment, today announced that the Board of Directors has declared a special, one-time cash dividend of $0.50 per share on its common stock as well as a regular dividend of $0.40 per share, for a total of $0.90 payable December 27, 2010 to shareholders of record December 17, 2010.
Women & Infants Hospital of Rhode Island has been named a Center of Excellence for Reproductive Resource Services by OptumHealth, an independent audit company.
The positive results of the first nationwide clinical study showing the benefits of an antiangiogenic agent in breast cancer therapy are reported in the Dec. 27 issue of the New England Journal of Medicine.
A practice-changing study, NRG Oncology clinical trial NRG-RTOG 9802, has demonstrated, for the first time, a survival benefit of adjuvant chemotherapy following radiotherapy over radiotherapy alone in certain subgroups of patients with high-risk, low-grade glioma (WHO classification: LGG, grade II), a type of brain tumor that originates from glial cells.
› Verified 3 days ago
Dr. Jeffrey Peter Rosen, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2699 Lee Rd Ste 100, Winter Park, FL 32789 Phone: 407-897-1363 Fax: 407-254-2557 | |
Dr. Mary Lynn Brown, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1285 Orange Ave, Winter Park, FL 32789 Phone: 407-647-2287 Fax: 407-643-1300 | |
John Anthony Anderson, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 255 N Lakemont Ave Ste 207, Winter Park, FL 32792 Phone: 844-407-4070 Fax: 407-743-3050 | |
Dr. Brian K. Barnard, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1285 Orange Ave, Winter Park, FL 32789 Phone: 407-647-2287 Fax: 407-643-2801 | |
Dr. Atif K Ahmed, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 255 N Lakemont Ave Ste 207, Winter Park, FL 32792 Phone: 844-407-4070 Fax: 609-581-1212 | |
John Adam Ruder, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 255 N Lakemont Ave Ste 207, Winter Park, FL 32792 Phone: 407-852-5333 Fax: 407-743-3050 | |
Dr. Kenneth A. Krumins, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1285 Orange Ave, Winter Park, FL 32789 Phone: 407-647-2287 Fax: 407-643-1300 |